<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cancer - After Diagnosis on VitaminDWiki</title>
    <link>http://localhost:1313/categories/cancer---after-diagnosis/</link>
    <description>Recent content in Cancer - After Diagnosis on VitaminDWiki</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 29 Mar 2024 00:00:00 +0000</lastBuildDate>
    <atom:link href="http://localhost:1313/categories/cancer---after-diagnosis/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Lots of Vitamin D needed weekly during Breast Cancer Treatment (mean 20,000 IU up to 140,000 IU)</title>
      <link>http://localhost:1313/posts/lots-of-vitamin-d-needed-weekly-during-breast-cancer-treatment-mean-20000-iu-up-to-140000-iu/</link>
      <pubDate>Fri, 29 Mar 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/lots-of-vitamin-d-needed-weekly-during-breast-cancer-treatment-mean-20000-iu-up-to-140000-iu/</guid>
      <description>&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;&lt;strong&gt;Personalized Vitamin D dosing&lt;/strong&gt; ranged from 2,000 IU to 140,000 weekly for Breast Cancer:&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;A range of 70 to 1&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Treating healthy people typically requires a range of Vitamin D of only 4 to 1&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;The women getting Breast Cancer treatment  were clearly not uniformly unhealthy&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;    &lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;The study failed to note improvement in outcomes vs women not getting Vitamin D&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Shorter treatment durations, less chemo used, less recurrence&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;course-of-vitamin-d-levels-in-newly-diagnosed-non-metastatic-breast-cancer-patients-over-one-year-with-quarterly-controls-and-substitution&#34;&gt;Course of Vitamin D Levels in Newly Diagnosed Non-Metastatic Breast Cancer Patients over One Year with Quarterly Controls and Substitution&lt;/h4&gt;&#xA;&lt;p&gt;Nutrients. 2024 Mar 15;16(6):854. &lt;a href=&#34;https://doi.org/10.3390/nu16060854.&#34;&gt;doi: 10.3390/nu16060854.&lt;/a&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>Following Digestive Cancer 2,000 IU of Vitamin D were given. Those whose Omega-3 levels rose had fewer Cancer problems – RCT</title>
      <link>http://localhost:1313/posts/following-digestive-cancer-2000-iu-of-vitamin-d-were-given-those-whose-omega-3-l-er-problems-rct/</link>
      <pubDate>Mon, 25 Mar 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/following-digestive-cancer-2000-iu-of-vitamin-d-were-given-those-whose-omega-3-l-er-problems-rct/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;interaction-of-vitamin-d-supplements-and-marine-n-3-fatty-acids-on-digestive-tract-cancer-prognosis&#34;&gt;Interaction of Vitamin D Supplements and Marine n-3 Fatty Acids on Digestive Tract Cancer Prognosis&lt;/h4&gt;&#xA;&lt;p&gt;Cancer Prognosis. Nutrients 2024,16,921. &lt;a href=&#34;https://doi.org/10.3390/nul6070921&#34;&gt;https://doi.org/10.3390/nul6070921&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Soichiro Fukuzato &lt;em&gt;©, Hironori Ohdaira 2, Yutaka Suzuki 2 and Mitsuyoshi Urashima 1,&lt;/em&gt;&lt;/p&gt;&#xA;&lt;p&gt;Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo 105-8461, Japan; &lt;a href=&#34;mailto:sunshine1.324@jikei.ac.jp&#34;&gt;sunshine1.324@jikei.ac.jp&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Department of Surgery, International University of Health and Welfare Hospital, Narita-shi 286-0048, Japan; &lt;a href=&#34;mailto:ohdaira@iuhw.ac.jp&#34;&gt;ohdaira@iuhw.ac.jp&lt;/a&gt; (H.O.); &lt;a href=&#34;mailto:yutaka@iuhw.ac.jp&#34;&gt;yutaka@iuhw.ac.jp&lt;/a&gt; (Y.S.)&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;600&#34;&gt;&#xA;&lt;p&gt;A meta-analysis suggested that marine n-3 polyunsaturated fatty acids (PUFAs), e.g., eicos- apentaenoic acid (EPA) and docosahexaenoic acid (DHA), might reduce cancer mortality. However, a randomized clinical trial of marine n-3 PUFA and vitamin D supplementation failed to verify this benefit. This study aimed to investigate the potential interaction between vitamin D supplementation and serum EPA and DHA levels. This post hoc analysis of the AMATERASU trial (UMIN000001977), a randomized controlled trial (RCT), included 302 patients with digestive tract cancers divided into two subgroups stratified by median serum levels of EPA + DHA into higher and lower halves. The 5-year relapse-free survival (RFS) rate was significantly higher in the higher half (80.9%) than the lower half (67.8%; hazard ratio (HR), 2.15; 95% CI, 1.29-3.59). In the patients in the lower EPA + DHA group, the 5-year RFS was significantly higher in the vitamin D (74.9%) than the placebo group (49.9%; HR, 0.43; 95% CI, 0.24-0.78). Conversely, vitamin D had no effect in the higher half, suggesting that vitamin D supplementation only had a significant interactive effect on RFS in the lower half (p for interaction = 0.03). These results suggest that vitamin D supplementation may reduce the risk of relapse or death by interacting with marine n-3 PUFAs.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Vitamin D is Dr. Marik&#39;s top repurposed drug for Cancer treatment</title>
      <link>http://localhost:1313/posts/vitamin-d-is-dr-mariks-top-repurposed-drug-for-cancer-treatment/</link>
      <pubDate>Mon, 26 Feb 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/vitamin-d-is-dr-mariks-top-repurposed-drug-for-cancer-treatment/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;from-book-marik-paul-e-cancer-care-the-role-of-repurposed-drugs-and-metabolic-interventions-in-treating-cancer&#34;&gt;From Book: Marik, Paul E. Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer&lt;/h4&gt;&#xA;&lt;p&gt;&lt;strong&gt;&lt;a href=&#34;https://www.amazon.com/Cancer-Care-Repurposed-Metabolic-Interventions/dp/0960121706/ref=sr_1_1?crid=CRK2FL18WY9G&amp;amp;dib=eyJ2IjoiMSJ9._OOEZPiCnwWiRqsVsviC4wynlzzfu3bWbnDVR06U3YykROrn9dDPIScvwqQTDvPW4Oyo48rHoHGPvuaPtm2gzAhGgMXL2GWir4SUoPq31cfFoiMFNDMISsXiNd0Q_EU0W8tLUrXPKD_e1TGXdTdetAEa_q_PvyVi_c2pyLgWAIaQd1T7WA_6D9GRRH8s0cFp.lh5B89LcKHWdeeN_YItr33TngqE29gQe_rhqskXRTE8&amp;amp;dib_tag=se&amp;amp;keywords=cancer+care+by+dr+paul+marik&amp;amp;qid=1708967346&amp;amp;sprefix=cancer+care%2Caps%2C201&amp;amp;sr=8-1&#34;&gt;Amazon Kindle $8&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;300&#34;&gt;&#xA;&lt;h4 id=&#34;tier-one-repurposed-drugs-strong-recommendation&#34;&gt;TIER ONE REPURPOSED DRUGS: STRONG RECOMMENDATION&lt;/h4&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;4&#34;&gt;&#xA;&lt;li&gt;Vitamin D3: 20,000 to 50,000 IU daily – NOTE: dosage should be adjusted according to blood vitamin D levels, aiming for a 25-OH level of at least 55-90 ng/dl&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;5&#34;&gt;&#xA;&lt;li&gt;Melatonin: start at 1 mg and increase to 20-30 mg at night (extended/slow release)&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;See VitaminDWiki &lt;a href=&#34;http://localhost:1313/posts/melatonin-and-vitamin-d-many-studies&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Melatonin and Vitamin D - many studies&#34;&gt;Melatonin and Vitamin D - many studies&lt;/a&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;6&#34;&gt;&#xA;&lt;li&gt;Green tea catechins: 500-1,000 mg daily&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;7&#34;&gt;&#xA;&lt;li&gt;Metformin: 1,000 mg twice daily&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;8&#34;&gt;&#xA;&lt;li&gt;Curcumin (nanocurcumin): 600 mg daily or as per the manufacturer’s suggested dosing&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;See VitaminDWiki &lt;a href=&#34;http://localhost:1313/posts/curcumin-helps-many-health-problems&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Curcumin helps many health problems&#34;&gt;Curcumin helps many health problems&lt;/a&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;9&#34;&gt;&#xA;&lt;li&gt;Mebendazole: 100-200 mg daily&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;10&#34;&gt;&#xA;&lt;li&gt;Omega 3 fatty acids: 2-4 g daily&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;See VitaminDWiki &lt;a href=&#34;http://localhost:1313/posts/overview-omega-3-many-benefits-include-helping-vitamin-domega-3&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Overview: Omega-3 many benefits include helping vitamin D|Omega-3&#34;&gt;Overview: Omega-3 many benefits include helping vitamin D|Omega-3&lt;/a&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;11&#34;&gt;&#xA;&lt;li&gt;Berberine: A daily dose of 1,000-1,500 mg or 500-600 mg two or three times daily. (Depending on blood glucose levels, metformin and berberine can be used together or alternating months)&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;See VitaminDWiki &lt;a href=&#34;http://localhost:1313/posts/berberine-an-antioxidant-that-activates-the-vitamin-d-receptor-many-studies&#34;&gt;Berberine: an antioxidant that activates the Vitamin D Receptor - many studies&lt;/a&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;12&#34;&gt;&#xA;&lt;li&gt;Atorvastatin: 40 mg twice daily. (Simvastatin 20 mg twice daily is an alternative.)&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;ol start=&#34;13&#34;&gt;&#xA;&lt;li&gt;Disulfiram: 80 mg three times daily or 500 mg once daily&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d&#34;&gt;Vitamin D&lt;/h4&gt;&#xA;&lt;p&gt;Vitamin D is synthesized in human skin after the photoisomerization of 7-dehydrocholesterol to pre-vitamin D3 under the influence of UV B radiation (wavelength, 280-315 nm). (314) The major factors influencing this process are either environmental (latitude, season, time of day, ozone and clouds, reflectivity of the surface) or personal (skin type, age, clothing, use of sunscreen, genetics). (315) From the skin, parental vitamin D3 (cholecalciferol) finds its way into the general circulation, and it is then metabolized in the liver to 25-hydroxyvitamin D3 &lt;span&gt;[25(OH)D3]&lt;/span&gt; (calcifediol). 25(OH)D3 is an immediate precursor metabolite to the active form of vitamin D3, 1,25-dihydroxyvitamin D3 &lt;span&gt;[1,25(OH)2D3]&lt;/span&gt; (calcitriol), that is the product of the mitochondrial CYP27B1-hydroxylase confined primarily but not entirely to the proximal tubular epithelial cell of the kidney. (315, 316) As vitamin D has a much shorter half-life than 25(OH)D3 (1-2 days versus 2-3 weeks), 25(OH)D3 is considered the best indicator of vitamin D status; hence 25(OH)D3 is the most widely used test indicating vitamin D status. (315, 316) A vitamin D level &amp;gt; 30 ng/ml is widely considered “normal” while a level between 20-30 ng/l is considered vitamin D insufficient and a level &amp;lt;20 ng/ml is considered vitamin D deficient. (315-317) However, more recent data suggests that a level &amp;gt; 50 ng/ml is desirable, and ideally targeting a level between 55-90 ng/ml is desirable. (314, 318-320) It may take many months or even years to achieve optimal levels in patients with low vitamin D levels (&amp;lt; 20 ng/ml) taking the standard recommended dose of 5,000 IU/day. It is therefore important that the optimal regimen for vitamin D supplementation be followed to achieve adequate circulating levels (see Table 3). (319, 320) Since the highest dose of commercially available vitamin D3 is 50,000 IU capsules, and due to its affordability (low cost) and better gastrointestinal absorption, we recommend using 50,000 IU D3 capsules for community setups.(314, 319, 320) Together, a number of these capsules can be taken as a bolus dose &lt;span&gt;[i.e., single upfront doses such as 100,000 to 400,000 IU]&lt;/span&gt;. However, the liver has a limited 25-hydroxylase capacity to convert vitamin D to 25(OH)D: thus, taking 50,000 IU capsules over a few days provides better bioavailability. (314, 319, 320) Vitamin D2 is manufactured through the ultraviolet irradiation of ergosterol from yeast, while vitamin D3 is synthesized trough the ultraviolet irradiation of 7-dehydrocholesterol from lanolin; both are used in over-the-counter vitamin D supplements. (315) Vitamin D2 has 30% of the biological activity of vitamin D3. It is best to include both Vitamin K2 (Menaquinone &lt;span&gt;[MK7]&lt;/span&gt; 100 mcg/day, or 800 mcg/week) and magnesium (250-500 mg/day) when doses of vitamin D &amp;gt; 8 000 IU/day are taken. (321, 322) It should be noted that vitamin K2 itself has anticancer properties and an inverse relationship exists between vitamin K2 (and not K1) intake and cancer mortality. (323-326) Table 3. Guidance on Upfront Loading Dose Regimens to Replenish Vitamin D Stores in the Body When serum vitamin D levels are available, the doses provided in this table can be used for the longer-term maintenance of serum 25(OH)D concentration above 50 ng/mL (125 nmol/L). The table provides the initial bolus dose, weekly dose, frequency, and duration of administration of oral vitamin D in non-emergency situations, in a non-obese, 70 kg adult.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Opioid and alcohol use disorders increase by 10% after some Cancers (Vit D can help)</title>
      <link>http://localhost:1313/posts/opioid-and-alcohol-use-disorders-increase-by-10-percent-after-some-cancers-vit-d-can-help/</link>
      <pubDate>Thu, 18 Jan 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/opioid-and-alcohol-use-disorders-increase-by-10-percent-after-some-cancers-vit-d-can-help/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;suds-rates-highest-in-head-neck-and-gastric-cancer-survivors&#34;&gt;SUDs rates highest in head, neck, and gastric cancer survivors&lt;/h4&gt;&#xA;&lt;p&gt;&lt;strong&gt;&lt;a href=&#34;https://www.mdedge.com/hematology-oncology/article/267385/mixed-topics/suds-rates-highest-head-neck-and-gastric-cancer?ecd=WNL_EVE_240118_mdedge&#34;&gt;MD Edge&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;&amp;ldquo;Nearly 10% of survivors of head, neck, esophageal, and gastric cancers experienced active  &lt;strong&gt;substance use disorders&lt;/strong&gt; , based on data from more than 6,000 individuals.&amp;rdquo;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Reporting on: Substance Use Disorders Among US Adult Cancer Survivors - Jan 2024 doi:10.1001/jamaoncol.2023.5785 PDF is behind a paywall&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Study only looked at solid cancers&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;&lt;strong&gt;Study Results&lt;/strong&gt;   This study included data from 6101 adult cancer survivors (56.91% were aged 65 years or older and 61.63% were female). Among lifetime cancer survivors, the prevalence of active SUD was 3.83% (SE, 0.32%). Substance use disorder was most prevalent in survivors of head and neck cancer (including mouth, tongue, lip, throat, and pharyngeal cancers; 9.36% &lt;span&gt;[SE, 2.47%]&lt;/span&gt;), esophageal and gastric cancer (9.42% &lt;span&gt;[SE, 5.51%]&lt;/span&gt;), cervical cancer (6.24% &lt;span&gt;[SE, 1.41%]&lt;/span&gt;), and melanoma (6.20% &lt;span&gt;[SE, 1.34%]&lt;/span&gt;).&lt;/p&gt;</description>
    </item>
    <item>
      <title>Better survival of many cancers if higher level of vitamin D</title>
      <link>http://localhost:1313/posts/better-survival-of-many-cancers-if-higher-level-of-vitamin-d/</link>
      <pubDate>Fri, 29 Dec 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/better-survival-of-many-cancers-if-higher-level-of-vitamin-d/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-and-cancer-survival-does-vitamin-d-supplementation-improve-the-survival-of-patients-with-cancer&#34;&gt;Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer?&lt;/h4&gt;&#xA;&lt;p&gt;Curr Oncol Rep 22, 62 (2020). &lt;a href=&#34;https://doi.org/10.1007/s11912-020-00929-4&#34;&gt;https://doi.org/10.1007/s11912-020-00929-4&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Taisuke Akutsu, Hikaru Kitamura, Shoko Himeiwa, Shinto Kitada, Tatsuya Akasu &amp;amp; Mitsuyoshi Urashima&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Table of Contents&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;250&#34;&gt;&#xA;&lt;p&gt;Purpose of Review&lt;/p&gt;&#xA;&lt;p&gt;Clinical evidence suggesting the beneficial effects of vitamin D on survival of patients with cancer has been accumulating. Recent articles were thoroughly reviewed to determine if there is enough evidence to conclude that vitamin D supplementation improves survival of patients with cancer.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Cancer Immunotherapy is enhanced by a Vitamin D loading dose</title>
      <link>http://localhost:1313/posts/cancer-immunotherapy-is-enhanced-by-a-vitamin-d-loading-dose/</link>
      <pubDate>Fri, 29 Dec 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/cancer-immunotherapy-is-enhanced-by-a-vitamin-d-loading-dose/</guid>
      <description>&lt;p&gt;&lt;strong&gt;2 Reasons Vitamin D &lt;a href=&#34;http://localhost:1313/posts/overview-loading-of-vitamin-dloading-doses&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Overview Loading of vitamin D|loading doses&#34;&gt;Overview Loading of vitamin D|loading doses&lt;/a&gt; are good:&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;ol&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;A loading dose provides the benefit of Vitamin D in &amp;lt;1 week instead of many months&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;A high concentration (loading dose) bypasses poor Vitamin D Receptors&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;p&gt;     Note: Many cancers have &amp;lt;a href=&amp;quot;/posts/breast-cancer-reduces-receptor-and-thus-blocks-vitamin-d-to-the-cells-several-st-amin-d-receptor&amp;quot; style=&amp;ldquo;color: red; text-decoration: underline;&amp;rdquo; title=&amp;ldquo;This post/category does not exist yet: Breast Cancer reduces receptor and thus blocks Vitamin D to the cells – several studies| &amp;ldquo;learned&amp;rdquo; how to deactivate the Vitamin D Receptor&amp;rdquo;&amp;gt;Breast Cancer reduces receptor and thus blocks Vitamin D to the cells – several studies| &amp;ldquo;learned&amp;rdquo; how to deactivate the Vitamin D Receptor&lt;/a&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>Diagnosed with Cancer - consider vitamin D - 2021</title>
      <link>http://localhost:1313/posts/diagnosed-with-cancer-consider-vitamin-d-2021/</link>
      <pubDate>Tue, 19 Dec 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/diagnosed-with-cancer-consider-vitamin-d-2021/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;just-been-diagnosed-with-cancer----uk-2021httpsvitamindukcomjust-been-diagnosed-with-cancer&#34;&gt;Just Been Diagnosed With Cancer ? - &lt;a href=&#34;https://vitaminduk.com/just-been-diagnosed-with-cancer/&#34;&gt;UK 2021&lt;/a&gt;&lt;/h4&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;p&gt;&lt;strong&gt;Describes&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;Vitamins, Minerals &amp;amp; Supplements&lt;/p&gt;&#xA;&lt;p&gt;Vitamin C&lt;/p&gt;&#xA;&lt;p&gt;Vitamin D&lt;/p&gt;&#xA;&lt;p&gt;Omega-3&lt;/p&gt;&#xA;&lt;p&gt;Sleep&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Does not seem to mention change of diet&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;||Book|Author&lt;/p&gt;&#xA;&lt;p&gt;Cancer as a Metabolic Disease|Professor Thomas Seyfried&lt;/p&gt;&#xA;&lt;p&gt;Metabolic Approach To Cancer|  Dr Nasha Winters and Jane Kelley&lt;/p&gt;&#xA;&lt;p&gt;Say No To Cancer| Patrick Holford&lt;/p&gt;&#xA;&lt;p&gt;The Rainbow Diet| Chris Woollams&lt;/p&gt;&#xA;&lt;p&gt;Eat To Beat Cancer|  Dr Rosy Daniel and Jane Sen&lt;/p&gt;&#xA;&lt;p&gt;The Cancer Fighting Diet|Dr Johannes Coy and Maren Franz&lt;/p&gt;</description>
    </item>
    <item>
      <title>Breast Cancer survival: 44% with just 10,000 IU of vitamin D per week, 33% with placebo – RCT</title>
      <link>http://localhost:1313/posts/breast-cancer-survival-44-percent-with-just-10000-iu-of-vitamin-d-per-week-33-pe-ith-placebo-rct/</link>
      <pubDate>Sun, 13 Aug 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/breast-cancer-survival-44-percent-with-just-10000-iu-of-vitamin-d-per-week-33-pe-ith-placebo-rct/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;efficacy-of-nutritional-intervention-in-breast-cancer-patients-a-randomized-clinical-case-control-trial&#34;&gt;Efficacy of nutritional intervention in breast cancer patients: a randomized clinical case control trial&lt;/h4&gt;&#xA;&lt;p&gt;INTERNATIONAL JOURNAL OF FOOD PROPERTIES 2023, VOL. 26, NO. 1, 2146-2159 &lt;a href=&#34;https://doi.org/10.1080/10942912.2023.2244686&#34;&gt;https://doi.org/10.1080/10942912.2023.2244686&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Aneela Qureshia, Farzana Siddiquea, Muhammad Arshadb, Waseem Khalidc, Shahid Bashirec&amp;rsquo;d, Ammar Ahmad Khanc, Syeda Mahvish Zahrae, Turky Omar Asarf, and Mayada Ahmad Al-Sameen9&lt;/p&gt;&#xA;&lt;p&gt;aInstitute of Food Science and Nutrition, University of Sargodha, Sargodha, Pakistan; bDepartment of Zoology, University of Sargodha, Sargodha, Pakistan; cUniversity Institute of Food Science and Technology, The University of Lahore, Lahore, Pakistan; dFaculty of Allied Health and Biological Sciences, Ibadat International University Islamabad, Islamabad, Pakistan; department of Environmental Design, Health and Nutritional Sciences, Allama Iqbal Open University, Islamabad, Pakistan; department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia; department of Horticulture Science, Faculty of Agriculture, University of Damascus, Damascus, Syria&lt;/p&gt;</description>
    </item>
    <item>
      <title>Vitamin D restricts new capillary growth (angiogenesis) in fat and cancers</title>
      <link>http://localhost:1313/posts/vitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancers/</link>
      <pubDate>Thu, 27 Jul 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/vitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancers/</guid>
      <description>&lt;p&gt;     &lt;strong&gt;&lt;span style=&#34;color:orange;&#34;&gt;Also restricted by some foods and drugs&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;targeting-angiogenesis-to-lose-weight---dr-greger-video-and-transcript-july2023&#34;&gt;Targeting Angiogenesis to Lose Weight - Dr. Greger video and transcript July 2023&lt;/h4&gt;&#xA;&lt;p&gt;&lt;strong&gt;&lt;a href=&#34;https://nutritionfacts.org/video/targeting-angiogenesis-to-lose-weight/&#34;&gt;5 minute Video&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;Angiogenesis is the creation of blood new vessels. Tumors use it to keep growing. Well, our fatty tissue also needs a blood supply to expand. So, might an anti-angiogenic approach work for weight loss, too? I’ll explore that in this video and the next.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Radiation therapy, used to treat some cancers, causes less damage if use Vitamin D (or Melatonin)</title>
      <link>http://localhost:1313/posts/radiation-therapy-used-to-treat-some-cancers-causes-less-damage-if-use-vitamin-d-or-melatonin/</link>
      <pubDate>Tue, 04 Jul 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/radiation-therapy-used-to-treat-some-cancers-causes-less-damage-if-use-vitamin-d-or-melatonin/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;ionizing-radiation-as-a-source-of-oxidative-stressthe-protective-role-of-melatonin-and-vitamin-d&#34;&gt;Ionizing Radiation as a Source of Oxidative Stress—The Protective Role of Melatonin and Vitamin D&lt;/h4&gt;&#xA;&lt;p&gt;Int. J. Mol. Sci. 2020, 21(16), 5804; &lt;a href=&#34;https://doi.org/10.3390/ijms21165804&#34;&gt;https://doi.org/10.3390/ijms21165804&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Jarosław Nuszkiewicz *ORCID,Alina Woźniak andKarolina Szewczyk-Golec *ORCID&lt;/p&gt;&#xA;&lt;p&gt;Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St, 85-092 Bydgoszcz, Poland&lt;/p&gt;&#xA;&lt;p&gt;Ionizing radiation (IR) has found widespread application in modern medicine, including medical imaging and radiotherapy. As a result, both patients and healthcare professionals are exposed to various IR doses. To minimize the negative side effects of radiation associated with oxidative imbalance, antioxidant therapy has been considered. In this review, studies on the effects of melatonin and vitamin D on radiation-induced oxidative stress are discussed.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Childhood Cancer Survivors have worse arteries due to anticancer therapy</title>
      <link>http://localhost:1313/posts/childhood-cancer-survivors-have-worse-arteries-due-to-anticancer-therapy/</link>
      <pubDate>Tue, 30 May 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/childhood-cancer-survivors-have-worse-arteries-due-to-anticancer-therapy/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-deficiency-and-carotid-media-intima-thickness-in-childhood-cancer-survivors&#34;&gt;Vitamin D Deficiency and Carotid Media-Intima Thickness in Childhood Cancer Survivors&lt;/h4&gt;&#xA;&lt;p&gt;Nutrients. 2023 May 16;15(10):2333. &lt;a href=&#34;https://doi.org/10.3390/nu15102333.&#34;&gt;doi: 10.3390/nu15102333.&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Eryk Latoch 1, Kacper Kozlowski 1, Katarzyna Kononczuk 1, Beata Zelazowska-Rutkowska 2, Monika Tomczuk-Ostapczuk 3, Maryna Krawczuk-Rybak 1, Katarzyna Muszynska-Roslan 1&lt;/p&gt;&#xA;&lt;p&gt;Childhood cancer survivors (CCS) are predisposed to developing numerous late effects of anticancer treatment later in life. The existing literature suggests that vitamin D deficiency (VDD) may influence cardiovascular abnormalities and metabolic diseases. The objectives of this study were to investigate the prevalence of VDD among childhood cancer survivors and examine the association of vitamin D deficiency and carotid intima-media thickness (IMT).&lt;/p&gt;</description>
    </item>
    <item>
      <title>Breast Cancer survivors with high vitamin D were 3.3 X less likely to have metastases</title>
      <link>http://localhost:1313/posts/breast-cancer-survivors-with-high-vitamin-d-were-33-x-less-likely-to-have-metastases/</link>
      <pubDate>Sun, 07 May 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/breast-cancer-survivors-with-high-vitamin-d-were-33-x-less-likely-to-have-metastases/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;low-baseline-vitamin-d-levels-increase-the-risk-of-bone-metastases-among-females-with-breast-cancer---hospital-based-cohort-study&#34;&gt;Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer - Hospital based cohort study&lt;/h4&gt;&#xA;&lt;p&gt;Cancer Epidemiol. 2023 May 4;85:102374. &lt;a href=&#34;https://doi.org/10.1016/j.canep.2023.102374&#34;&gt;doi: 10.1016/j.canep.2023.102374&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Rehab F Mohamed 1, Dina B S Barakat 2, Samir Eid 2, Dalia T Kamal 3, Maha S Elnaggar 2&lt;/p&gt;&#xA;&lt;p&gt;Background: Serum vitamin D (Vit-D) has been linked to the development of breast cancer (BC); however, their effect on pathological features and outcomes is undetermined. The purpose of this study was to examine the prognostic significance of baseline Vit-D levels and their effect on clinical outcomes.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
